The filing could come as early as next week and would cover Wegovy as an obesity treatment, which could widen access in Korea.
Recap by typeshit. Post by Facebook on Facebook.
Costco is adding Novo Nordisk's semaglutide shots to what it offers. Details are thin here, so tap through for how pricing and access will work.
An explainer on talking to a provider about whether Wegovy fits you, plus a reminder that insurance may not pay for it.
Khunti shares real-world data on over a million UK adults using telehealth for obesity care, where 90% started on tirzepatide before a major price hike changed prescribing.
Polskie Radio reports a Wegovy price cut in China, coming soon after the drug's approval there. Tap through for the details.
ScienceAlert reports the rate among people who never took the drugs was 9%, a gap researchers say is worth investigating further.
Covers hair and nail findings, vision loss lawsuits both drugmakers dispute, and new WHO guidance against drug treatment for obesity in kids under 10.
Loading…